Study on the Effectiveness of Rhukot Forte Tablet in Improving Clinical Outcomes in Individuals with Rheumatoid Arthritis

Effectiveness of Rhukot forte Tablet in Rheumatoid Arthritis - A QuasiExperimental study - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/12/098494

Enrollment

Registered

2025-12-04

Start date

Unknown

Completion date

Unknown

Last updated

2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissue

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Participants with Joint pain & stiffness satisfying the ACR classification criteria for Rheumatoid Arthritis

Exclusion criteria

Exclusion criteria: 1. Known systemic inflammatory conditions other than RA and participants with ANA positive are also excluded 2. Known case of Malignancy 3. Known Cardiovascular disorders (such as Coronary artery disease, Rheumatic heart disease, congenital heart disease and Cardiac myopathy)

Design outcomes

Primary

Measure	Time frame
Noticing improvements in joint pain, swelling, and tenderness can be a significant relief Timepoint: 14DAYS	—

Secondary

Measure	Time frame
Improved blood parameters: reduced ESR, CRP, RA Factor, and Serum Uric AcidTimepoint: 14 DAYS	—

Countries

India

Contacts

Public ContactDr Anoop AK

Vaidyaratnam P S Variers Aryavaidyasala Kottakkal

researchmarketing@aryavaidyasala.com04832806520

Outcome results